Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 8Thoracic 3Gastrointestinal 3Tumor-Agnostic 1Gynecologic 1Genitourinary 1

Conditions

Lung Neoplasms 3

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Relaxation Therapy × Thoracic × Clear all
NCT05339022 2025-11-21

Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial

Ohio State University Comprehensive Cancer Center

Phase NA Completed
100 enrolled
Thoracic

Lung Neoplasms

NCT04229381 2023-11-15

ROAR-LCT

Ohio State University Comprehensive Cancer Center

Phase NA Completed
18 enrolled 9 charts
Thoracic

Lung Neoplasms

NCT02938104 2018-03-22

Multimodal Prehabilitation to Enhance Functional Recovery After Lung Surgery

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Completed
120 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡